396 related articles for article (PubMed ID: 29912605)
1. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
2. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
Abdel-Wahab N; Safa H; Abudayyeh A; Johnson DH; Trinh VA; Zobniw CM; Lin H; Wong MK; Abdelrahim M; Gaber AO; Suarez-Almazor ME; Diab A
J Immunother Cancer; 2019 Apr; 7(1):106. PubMed ID: 30992053
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitors in Organ Transplant Patients.
Kittai AS; Oldham H; Cetnar J; Taylor M
J Immunother; 2017 Sep; 40(7):277-281. PubMed ID: 28719552
[TBL] [Abstract][Full Text] [Related]
4. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
5. Costimulation blockade: current perspectives and implications for therapy.
Kinnear G; Jones ND; Wood KJ
Transplantation; 2013 Feb; 95(4):527-35. PubMed ID: 23129000
[TBL] [Abstract][Full Text] [Related]
6. What's new in childhood organ transplantation.
Sudan D; Bacha EA; John E; Bartholomew A
Pediatr Rev; 2007 Dec; 28(12):439-53. PubMed ID: 18055642
[No Abstract] [Full Text] [Related]
7. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
[TBL] [Abstract][Full Text] [Related]
8. The Bad and the Good News on Cancer Immunotherapy: Implications for Organ Transplant Recipients.
Maggiore U; Pascual J
Adv Chronic Kidney Dis; 2016 Sep; 23(5):312-316. PubMed ID: 27742386
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of complications of immunosuppression: is the time right for hand transplantation?
Brenner MJ; Tung TH; Jensen JN; Mackinnon SE
J Bone Joint Surg Am; 2002 Oct; 84(10):1861-70. PubMed ID: 12377920
[No Abstract] [Full Text] [Related]
10. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
[TBL] [Abstract][Full Text] [Related]
11. Conventional and novel approaches to immunosuppression.
Floreth T; Bhorade SM; Ahya VN
Clin Chest Med; 2011 Jun; 32(2):265-77. PubMed ID: 21511089
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitors in Transplantation-A Case Series and Comprehensive Review of Current Knowledge.
Delyon J; Zuber J; Dorent R; Poujol-Robert A; Peraldi MN; Anglicheau D; Lebbe C
Transplantation; 2021 Jan; 105(1):67-78. PubMed ID: 32355121
[TBL] [Abstract][Full Text] [Related]
13. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.
Qin CX; Moore LW; Anjan S; Rahamimov R; Sifri CD; Ali NM; Morales MK; Tsapepas DS; Basic-Jukic N; Miller RA; van Duin D; Santella RN; Wadei HM; Shah PD; Gage N; Malinis M; Aslam S; Todesco E; Werbel WA; Avery RK; Segev DL
Transplantation; 2021 Nov; 105(11):e265-e266. PubMed ID: 34310531
[No Abstract] [Full Text] [Related]
14. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary infections following solid organ transplantation].
Müller V; Kováts Z; Horváth G
Orv Hetil; 2012 Jun; 153(23):899-903. PubMed ID: 22668590
[TBL] [Abstract][Full Text] [Related]
16. Poor Outcomes With the Use of Checkpoint Inhibitors in Kidney Transplant Recipients.
Venkatachalam K; Malone AF; Heady B; Santos RD; Alhamad T
Transplantation; 2020 May; 104(5):1041-1047. PubMed ID: 31415036
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-targeted therapy for the management of solid organ transplant recipients.
Szczepanik A; Iasella CJ; McDyer JF; Ensor CR
Hum Immunol; 2019 Mar; 80(3):184-190. PubMed ID: 30562564
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in solid organ-transplant recipients and impact on nutrition support.
Wilson NK; Kataria AD
Nutr Clin Pract; 2024 Feb; 39(1):109-116. PubMed ID: 38030572
[TBL] [Abstract][Full Text] [Related]
19. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous infections from viral sources in solid organ transplant recipients.
Ilyas M; Maganty N; Sharma A
J Clin Virol; 2017 Dec; 97():33-37. PubMed ID: 29096391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
